Sharper & Granite LLC Buys 380 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Sharper & Granite LLC increased its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 12,053 shares of the exchange traded fund’s stock after acquiring an additional 380 shares during the quarter. Sharper & Granite LLC’s holdings in SPDR S&P Biotech ETF were worth $1,085,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Bank of New York Mellon Corp lifted its stake in SPDR S&P Biotech ETF by 15.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 5,590 shares of the exchange traded fund’s stock worth $518,000 after purchasing an additional 744 shares in the last quarter. BOKF NA increased its holdings in shares of SPDR S&P Biotech ETF by 65.5% in the second quarter. BOKF NA now owns 1,390 shares of the exchange traded fund’s stock worth $129,000 after purchasing an additional 550 shares during the period. Envestnet Asset Management Inc. raised its position in shares of SPDR S&P Biotech ETF by 12.5% in the second quarter. Envestnet Asset Management Inc. now owns 186,400 shares of the exchange traded fund’s stock worth $17,281,000 after buying an additional 20,685 shares in the last quarter. Greenwich Wealth Management LLC boosted its stake in SPDR S&P Biotech ETF by 10.3% during the second quarter. Greenwich Wealth Management LLC now owns 11,505 shares of the exchange traded fund’s stock valued at $1,067,000 after buying an additional 1,073 shares during the period. Finally, Bcwm LLC boosted its stake in SPDR S&P Biotech ETF by 4.2% during the second quarter. Bcwm LLC now owns 42,915 shares of the exchange traded fund’s stock valued at $3,979,000 after buying an additional 1,742 shares during the period.

SPDR S&P Biotech ETF Stock Down 0.3 %

NYSEARCA:XBI opened at $89.13 on Tuesday. The stock has a market cap of $6.79 billion, a P/E ratio of 11.47 and a beta of 1.11. The business’s 50-day moving average price is $95.28 and its two-hundred day moving average price is $97.10. SPDR S&P Biotech ETF has a twelve month low of $81.14 and a twelve month high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.